Skip to main content

Table 4 Post TAVI pacemaker implantation analysis

From: Short term clinical outcomes and analysis of risk factors for pacemaker implantation: a single center experience of self-expandable TAVI valves

Post TAVI PPM analysis (n = 15)  
Indications  
AVB type III 8 /15 (53.3%)
LBBB, HR < 40 bpm; symptoms 3/15 (20%)
Tachy-brady syndrome with rate < 40 bpm 1/15 (6.7%)
Slow Atrial fibrillation < 40 bpm; hypotension 1/15 (6.7%)
Slow Atrial fibrillation;
long pause > 5 s
1/15 (6.7%)
Junctional/ Atrial fibrillation, with HR < 40 bpm 1/15 (6.7%)
DDDR 5/15 (33.3%)
VVIR 10/15 (66.6%)
Timing for PPM post TAVI  
Within 24 h 4/15 (26.7%)
D1-D3 6/16 (37.5%)
>D3 – D7 5/15 (33.3%)
More than 1 week 3/15 (20%)
VP & AP < 5% at 1 year of interrogation 6/15 (40%)
- AVB III as indication 3/6
- Tachy-brady 1/6
- Long pause 1/6
- Slow AF + LBBB + rate < 40 1 /6
Time for implant post TAVI for patients with VP/AP < 5% & ECG native > 60 bpm at Follow up
- Within 24 h 2/6
- D1 to D3 1/6
- D3 to D7 2/6
- More than 1 week 1/6